Hikma Pledges $1 Billion to Expand US Generic Drug Production: Major Boost for Domestic Healthcare Supply

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines

Next phase builds on 34+ years of serving the needs of US patients and healthcare providers

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines - PressReach

Open the article to view the coverage from pressreach.com

Hikma Pledges $1 Billion to Expand US Generic Drug Production: Major Boost for Domestic Healthcare Supply

Hikma's $1B investment expands US-made generic medicines production across 4 states. New facilities will boost annual capacity beyond 12 billion doses. Learn expansion details.